GlaxoSmithKline Plc has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children, according to people familiar with the settlements. The settlements, which provide an average payout of more than $1.2 million to families of affected…
A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files. Jennifer Berg of Watertown sued SmithKline Beecham, doing business as GlaxoSmithKline, in October 2007. The…
In 2005, the Food and Drug Administration (FDA) warned doctors about a study showing that babies born to women who took Paxil during the first trimester of pregnancy had a higher rate of major birth defects. The study, which involved 3,500 pregnant women, showed that those on Paxil were twice…
In treating diabetes, it might not matter much whether the Food and Drug Administration halts sales of the drug Avandia. An FDA committee of outside experts met last week to provide advice on whether any regulatory action — from stronger warnings to removal — is needed. The FDA has the…
Patients undergoing arthroscopic shoulder surgery have received pain pumps to assist in their recovery. Now a new study suggests these pumps may deliver too much medicine, destroying cartilage and leading to a condition known as Postarthroscopic Glenohumeral Chondrolysis. A study by The American Journal of Sports Medicine identified intra-articular pain…
The New York Times (7/16, B2, Jolly, Harris) reports that UK pharmaceutical maker GlaxoSmithKline announced on July 15 that “it would take a second-quarter charge of $2.36 billion related to legal cases involving its drugs Avandia [rosiglitazone] and Paxil [paroxetine].” This announcement comes one “day after an American medical advisory…
An FDA panel has made a recommendation to the agency that the controversial diabetes drug Avandia should either be taken off the market or its sales should be severely restricted. Avandia and its maker, GlaxoSmithKline, have recently come under fire for trial results that reveal that patients taking Avandia are…
The New York Times (7/5) editorialized that the recent controversy over the diabetes drug Avandia — with “two major studies” saying it “raises the risk of cardiovascular ailments” and the third yet-to-be-published study that “seemed to exonerate” the drug — should probably lead patients to ask their doctors about alternatives.…
The Los Angeles Times (7/1, Rick) reports that Avastin (bevacizumab) “can cause significant kidney damage in some patients,” according to a new study. Researchers, “reporting in this month’s issue of the Journal of the American Society of Nephrology…wrote that patients on Avastin were at increased risk of severe protein loss…
We were recently featured on Dallas CBS Channel 11 evening news. Please click here to read the interview and watch the video link. Our client suffered massive brain damage following the use of Yaz. Legal News Tags, attorney yasmin, attorney yaz, birth control yasmin, birth control yaz, blood clots, Dallas…